UTMC

See more from

UToledo Continues COVID-19 Vaccine Distribution Under Ohio’s Phased Approach

January 13, 2021

As the Ohio Department of Health’s phased approach to vaccination moves from Phase 1A to Phase 1B, the vaccine will be offered to a broader cross-section of the community beginning the week of Jan. 19.


Rapid COVID-19 Tests Available This Month for Faculty, Staff and Students

January 11, 2021

The antigen-based tests, performed in partnership with The University of Toledo Medical Center and collected via a shallow nasal swab, will provide results in approximately 30 minutes.


Supporting Patients

January 11, 2021

Lindsay Bowman, left, owner of LBs Circuit Training, and members of the gym raised donations to provide bags with natural cleaning products, snacks and gas cards for radiation and infusion patients at Eleanor N. Dana Cancer Center at The University of Toledo Medical Center.


UTMC patients part of national study on COVID drugs

January 7, 2021

Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the hospital’s participation in a nationwide NIH study examining a pair of monoclonal antibodies to treat COVID-19. The study is aimed at quickly identifying therapeutics worthy of larger clinical trials. Read: UTMC patients part of national study on COVID drugs


University of Toledo Medical Center takes part in national drug study for COVID-19

January 6, 2021

Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about hospital’s participation in a nationwide NIH study aimed at quickly and efficiently identifying additional therapeutics for COVID-19 worthy of larger clinical trials.


UTMC Among First Hospitals Participating in National COVID-19 Drug Study

January 6, 2021

Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the importance of developing new COVID-19 therapies and how UTMC is playing a role by participating in a nationwide NIH study of experimental treatments.


UTMC Among First Hospitals Participating in National COVID-19 Drug Study

January 5, 2021

The proof-of-concept study is intended to quickly screen out ineffective experimental treatments while rapidly advancing the deployment of therapeutics that show significant benefit to hospitalized COVID-19 patients.


UTMC begins participation in national coronavirus treatment study

January 5, 2021

Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, discusses how UTMC has begun recruiting patients to participate in an NIH study seeking to identify which coronavirus treatments are most effective and deserve more attention in clinical trials. Read: UTMC begins participation in national coronavirus treatment study


UTMC looks to emerge from dark year

January 3, 2021

UToledo Interim President Gregory Postel and UTMC CEO Rick Swaine discuss momentum at the hospital and plans for 2021. Read: UTMC looks to emerge from dark year


Renewed optimism: UTMC-Toledo Clinic partnership finds early success

December 25, 2020

UTMC CEO Rick Swaine discusses the partnership between UTMC and Toledo Clinic. Read: Renewed optimism: UTMC-Toledo Clinic partnership finds early success